(Q37931256)

25 August 2017

1 reference

title

NK cells and their receptors during viral infections (English)

1 reference

25 August 2017

1

Emanuela Marcenaro

1 reference

25 August 2017

6

Alessandro Moretta

1 reference

PubMed ID

21913830

25 August 2017

Mariella Della Chiesa

series ordinal

4

object named as

Mariella Della Chiesa

1 reference

25 August 2017

2

Simona Carlomagno

1 reference

25 August 2017

5

Silvia Parolini

1 reference

25 August 2017

3

Silvia Pesce

1 reference

25 August 2017

7

Simona Sivori

1 reference

PubMed ID

21913830

25 August 2017

language of work or name

1 reference

1 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

3

1 reference

25 August 2017

9

1 reference

25 August 2017

1075-1086

1 reference

Innate or adaptive immunity? The example of natural killer cells

25 August 2017

1 reference

Receptors for HLA class-I molecules in human natural killer cells.

21 January 2018

1 reference

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

The biology of human natural killer-cell subsets

21 January 2018

1 reference

Evolutionary struggles between NK cells and viruses

21 January 2018

1 reference

Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.

21 January 2018

1 reference

NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

21 January 2018

1 reference

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

21 January 2018

1 reference

Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin.

21 January 2018

1 reference

Specific and nonspecific NK cell activation during virus infection

21 January 2018

1 reference

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

21 January 2018

1 reference

Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein

21 January 2018

1 reference

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

MHC class Ib molecules bridge innate and acquired immunity

21 January 2018

1 reference

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

21 January 2018

1 reference

Natural killer cell signaling pathways

21 January 2018

1 reference

Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells

21 January 2018

1 reference

Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j)

21 January 2018

1 reference

Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation

21 January 2018

1 reference

A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation

21 January 2018

1 reference

Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors

21 January 2018

1 reference

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A * 11 while diminishing avidity for HLA-C

21 January 2018

1 reference

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

21 January 2018

1 reference

Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

21 January 2018

1 reference

HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection

21 January 2018

1 reference

NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.

21 January 2018

1 reference

Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.

21 January 2018

1 reference

MHC class I molecules and KIRs in human history, health and survival

21 January 2018

1 reference

Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells

21 January 2018

1 reference

CD94 is essential for NK cell-mediated resistance to a lethal viral disease

21 January 2018

1 reference

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

21 January 2018

1 reference

Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.

21 January 2018

1 reference

A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.

21 January 2018

1 reference

p46, a novel natural killer cell-specific surface molecule that mediates cell activation

21 January 2018

1 reference

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

21 January 2018

1 reference

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

21 January 2018

1 reference

Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46

21 January 2018

1 reference

NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human

21 January 2018

1 reference

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells

21 January 2018

1 reference

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

21 January 2018

1 reference

Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase

21 January 2018

1 reference

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46

21 January 2018

1 reference

Recognition of viral hemagglutinins by NKp44 but not by NKp30.

21 January 2018

1 reference

H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44.

21 January 2018

1 reference

Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense

21 January 2018

1 reference

Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?

21 January 2018

1 reference

Natural killer receptors: the burden of a name

21 January 2018

1 reference

The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions

21 January 2018

1 reference

Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity

21 January 2018

1 reference

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

21 January 2018

1 reference

2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48

21 January 2018

1 reference

NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease

21 January 2018

1 reference

Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells.

21 January 2018

1 reference

Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction.

21 January 2018

1 reference

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

21 January 2018

1 reference

Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets

21 January 2018

1 reference

CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells

21 January 2018

1 reference

Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors

21 January 2018

1 reference

Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC.

21 January 2018

1 reference

Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction

21 January 2018

1 reference

The role of chemokine receptors in primary, effector, and memory immune responses

21 January 2018

1 reference

Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

21 January 2018

1 reference

Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation

21 January 2018

1 reference

Human natural killer cell development

21 January 2018

1 reference

Human natural killer cell development and biology

21 January 2018

1 reference

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

21 January 2018

1 reference

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo

21 January 2018

1 reference

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets

21 January 2018

1 reference

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

21 January 2018

1 reference

Human NK cell education by inhibitory receptors for MHC class I.

21 January 2018

1 reference

Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates

21 January 2018

1 reference

Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment

21 January 2018

1 reference

Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.

21 January 2018

1 reference

Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines

21 January 2018

1 reference

Natural-killer cells and dendritic cells: "l'union fait la force".

21 January 2018

1 reference

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

21 January 2018

1 reference

Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro

21 January 2018

1 reference

Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells.

21 January 2018

1 reference

Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?

21 January 2018

1 reference

Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4.

21 January 2018

1 reference

IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors

21 January 2018

1 reference

NK cells at the interface between innate and adaptive immunity

21 January 2018

1 reference

Early liaisons between cells of the innate immune system in inflamed peripheral tissues.

21 January 2018

1 reference

Specific memory within innate immune systems

21 January 2018

1 reference

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity?

21 January 2018

1 reference

T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

21 January 2018

1 reference

Adaptive immune responses mediated by natural killer cells

21 January 2018

1 reference

Adaptive immune features of natural killer cells

21 January 2018

1 reference

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors

21 January 2018

1 reference

Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection

21 January 2018

1 reference

Natural Killer Cells During Primary Varicella Zoster Virus Infection

21 January 2018

1 reference

Human natural killer cell deficiencies

21 January 2018

1 reference

NK cells and immune "memory"

21 January 2018

1 reference

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.

21 January 2018

1 reference

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

21 January 2018

1 reference

Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

21 January 2018

1 reference

The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C

21 January 2018

1 reference

Severe herpesvirus infections in an adolescent without natural killer cells

21 January 2018

1 reference

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education

21 January 2018

1 reference

Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection

21 January 2018

1 reference

NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies

21 January 2018

1 reference

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus

21 January 2018

1 reference

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

21 January 2018

1 reference

CD56 negative NK cells: origin, function, and role in chronic viral disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.11.99

1 reference

25 August 2017

1 reference

PubMed ID

21913830